Xoxe Dry Syrup contains Cefuroxime 125 mg, a second-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. It is indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, and otitis media caused by susceptible strains of bacteria. Cefuroxime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Xoxe Dry Syrup is formulated for oral suspension, ensuring ease of administration, particularly in pediatric patients who have difficulty swallowing tablets. The dry syrup should be reconstituted with the appropriate amount of water as per the instructions provided, and the suspension should be shaken well before each use to ensure uniform dosing. The dosage and duration of therapy depend on the severity and type of infection, as well as patient-specific factors such as age and renal function. Common adverse effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort. Hypersensitivity reactions, although rare, may occur and warrant immediate discontinuation. Xoxe Dry Syrup should be used with caution in patients with a history of penicillin or cephalosporin allergy. It is essential to complete the full prescribed course to prevent the development of antibiotic resistance.